亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應(yīng)美洛昔康 供應(yīng)cas:71125-38-7

 
 
單價(jià) 870.00 / 公斤對(duì)比
銷量 暫無(wú)
發(fā)貨 湖北武漢市付款后3天內(nèi)
庫(kù)存 300公斤起訂25公斤
品牌 康寶泰
型號(hào) 71125-38-7
規(guī)格 醫(yī)藥級(jí)
過(guò)期 長(zhǎng)期有效
更新 2014-11-14 16:21
 

湖北康寶泰精細(xì)化工公司

企業(yè)會(huì)員第14年
資料未認(rèn)證
保證金未繳納
  • 湖北-武漢市
  • 上次登錄 2016-12-14
  • 向生 (先生)   銷售經(jīng)理
詳細(xì)說(shuō)明

美洛昔康

產(chǎn)品名稱:美洛昔康

別名:4-羥基-2-甲基-N-(5-甲基-1,3-噻唑-2-基)-2H-1,2-苯并噻嗪-3-羧酸乙酯1,1-二氧化物

英文名稱:Meloxicam

CAS號(hào):71125-38-7

分子式:C14H13N3O4S2

分子量:351.4

外觀:黃色結(jié)晶性粉末

含量:≥99%

用途:本品為非甾體抗炎藥。在動(dòng)物模型上具有鎮(zhèn)痛、抗炎、解熱作用。其機(jī)理可能與抑制前列腺素的合成有關(guān)。
適應(yīng)癥:適用于類風(fēng)濕性關(guān)節(jié)炎的癥狀治療、疼痛性骨關(guān)節(jié)炎(關(guān)節(jié)病、退行性骨關(guān)節(jié)?。┑陌Y狀治療。

包裝:25KG/桶

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
供應(yīng)鹽酸苯海拉明 優(yōu)質(zhì)現(xiàn)貨147-24-0 供應(yīng)美索巴莫 cas:532-03-6 供應(yīng)雙氯芬酸二乙胺鹽 cas:78213-16-8 供應(yīng)氫溴酸右美沙芬 cas:6700-34-1 供應(yīng)腺嘌呤 CAS:73-24-5 供應(yīng)培美曲塞二鈉 cas:357166-30-4 供應(yīng)丙戊酸鈉 cas:1069-66-5 現(xiàn)貨供應(yīng)
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |